Drugplain

Methylphenidate Hydrochloride Extended-Release 60 mg/1

methylphenidate hydrochloride · CAPSULE, EXTENDED RELEASE · SpecGx LLC

No Recall HistoryCurrently in Shortage
Plain English

Methylphenidate hydrochloride extended-release is a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy by increasing focus and reducing impulsive behavior. This stimulant medication comes as an extended-release capsule that releases the active ingredient gradually throughout the day.

Key Facts

Brand Name
Methylphenidate Hydrochloride Extended-Release
Generic Name
methylphenidate hydrochloride
NDC Code (Product)
0406-1860
Manufacturer
SpecGx LLC
Strength
60 mg/1
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
ANDA203583
Marketing Start
09/29/2015

Recall History

No Recall History

Frequently Asked Questions

What is Methylphenidate Hydrochloride Extended-Release used for?

Methylphenidate hydrochloride extended-release is a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy by increasing focus and reducing impulsive behavior. This stimulant medication comes as an extended-release capsule that releases the active ingredient gradually throughout the day.

Is Methylphenidate Hydrochloride Extended-Release a controlled substance?

Yes, Methylphenidate Hydrochloride Extended-Release is classified as CII under the DEA Controlled Substances Act.

What is the generic name for Methylphenidate Hydrochloride Extended-Release?

The generic name for Methylphenidate Hydrochloride Extended-Release is methylphenidate hydrochloride. There are 12 other brand versions of methylphenidate hydrochloride.

What is the NDC code for Methylphenidate Hydrochloride Extended-Release 60 mg/1?

The NDC (National Drug Code) for Methylphenidate Hydrochloride Extended-Release 60 mg/1 is 0406-1860, listed by SpecGx LLC.